Will Lewis

Will Lewis has an extensive leadership background in the biopharmaceutical sector, currently serving as the Chair of the Board of Directors at NewAmsterdam Pharma Corporation since January 2024. Lewis holds the position of Chairman and Chief Executive Officer at Insmed Incorporated, a role maintained since September 2012. Additionally, Will served as Board Chair for Adrestia Therapeutics from November 2022 to July 2023 and as Chairperson of the Board for BioNJ from January 2021 to January 2023. Past experiences also include membership on the Board of Directors for Helix Acquisition Corp. and a board member role at uniQure. Academically, Will Lewis earned a Juris Doctor and a Master of Business Administration from Case Western Reserve University, along with a Bachelor of Arts from Oberlin College and a high school diploma from Hawken School.